269 related articles for article (PubMed ID: 21097674)
1. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.
Sarantopoulos S; Stevenson KE; Kim HT; Washel WS; Bhuiya NS; Cutler CS; Alyea EP; Ho VT; Soiffer RJ; Antin JH; Ritz J
Blood; 2011 Feb; 117(7):2275-83. PubMed ID: 21097674
[TBL] [Abstract][Full Text] [Related]
2. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
Sarantopoulos S; Stevenson KE; Kim HT; Cutler CS; Bhuiya NS; Schowalter M; Ho VT; Alyea EP; Koreth J; Blazar BR; Soiffer RJ; Antin JH; Ritz J
Blood; 2009 Apr; 113(16):3865-74. PubMed ID: 19168788
[TBL] [Abstract][Full Text] [Related]
3. B cells in chronic graft-versus-host disease.
McManigle W; Youssef A; Sarantopoulos S
Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
[TBL] [Abstract][Full Text] [Related]
4. Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.
Jacobson CA; Sun L; Kim HT; McDonough SM; Reynolds CG; Schowalter M; Koreth J; Cutler CS; Ho VT; Alyea EP; Armand P; Blazar BR; Soiffer RJ; Antin JH; Ritz J; Sarantopoulos S
Biol Blood Marrow Transplant; 2014 May; 20(5):668-75. PubMed ID: 24462743
[TBL] [Abstract][Full Text] [Related]
5. B cells in chronic graft-versus-host disease.
Sarantopoulos S; Blazar BR; Cutler C; Ritz J
Biol Blood Marrow Transplant; 2015 Jan; 21(1):16-23. PubMed ID: 25452031
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
[TBL] [Abstract][Full Text] [Related]
7. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
Front Immunol; 2020; 11():1505. PubMed ID: 32849514
[TBL] [Abstract][Full Text] [Related]
8. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
Allen JL; Fore MS; Wooten J; Roehrs PA; Bhuiya NS; Hoffert T; Sharf A; Deal AM; Armistead P; Coghill J; Gabriel DA; Irons R; Essenmacher A; Shea TC; Richards K; Cutler C; Ritz J; Serody J; Baldwin AS; Sarantopoulos S
Blood; 2012 Sep; 120(12):2529-36. PubMed ID: 22896003
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab.
Kennedy VE; Sahaf B; Wu F; Ehlinger ZJ; Arai S; Miklos DB
Transplant Cell Ther; 2024 May; 30(5):518.e1-518.e13. PubMed ID: 38458479
[TBL] [Abstract][Full Text] [Related]
10. Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.
Peng Y; Chen X; Liu Q; Xu D; Zheng H; Liu L; Liu Q; Liu M; Fan Z; Sun J; Li X; Zou R; Xiang AP
Stem Cells Transl Med; 2014 Sep; 3(9):1023-31. PubMed ID: 25015640
[TBL] [Abstract][Full Text] [Related]
11. Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.
Kuzmina Z; Greinix HT; Weigl R; Körmöczi U; Rottal A; Frantal S; Eder S; Pickl WF
Blood; 2011 Feb; 117(7):2265-74. PubMed ID: 21063025
[TBL] [Abstract][Full Text] [Related]
12. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
[TBL] [Abstract][Full Text] [Related]
13. BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
Jia W; Poe JC; Su H; Anand S; Matsushima GK; Rathmell JC; Maillard I; Radojcic V; Imai K; Reyes NJ; Cardona DM; Li Z; Suthers AN; Curry-Chisolm IM; DiCioccio RA; Saban DR; Chen BJ; Chao NJ; Sarantopoulos S
Blood; 2021 May; 137(18):2544-2557. PubMed ID: 33534893
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.
Rozmus J; Kariminia A; Abdossamadi S; Storer BE; Martin PJ; Lee SJ; Wolff D; Arora M; Cutler C; Schultz KR
Biol Blood Marrow Transplant; 2019 Mar; 25(3):451-458. PubMed ID: 30447393
[TBL] [Abstract][Full Text] [Related]
15. The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection.
Hilgendorf I; Mueller-Hilke B; Kundt G; Holler E; Hoffmann P; Edinger M; Freund M; Wolff D
Transpl Int; 2012 Jan; 25(1):87-96. PubMed ID: 22098606
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of affected tissue may guide cGVHD treatment decisions.
Williams KM; Ostrow LW; Loeb DM; Chung T; Cohn RD; Corse AM; Mammen AL; Chen AR
Bone Marrow Transplant; 2012 May; 47(5):731-3. PubMed ID: 21927032
[TBL] [Abstract][Full Text] [Related]
17. The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.
van Dorp S; Resemann H; te Boome L; Pietersma F; van Baarle D; Gmelig-Meyling F; de Weger R; Petersen E; Minnema M; Lokhorst H; Ebeling S; Beijn SJ; Knol EF; van Dijk M; Meijer E; Kuball J
Haematologica; 2011 Sep; 96(9):1380-4. PubMed ID: 21546493
[TBL] [Abstract][Full Text] [Related]
18. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
Front Immunol; 2019; 10():334. PubMed ID: 30894856
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of rituximab in chronic graft-versus-host disease.
Bates JS; Engemann AM; Hammond JM
Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
[TBL] [Abstract][Full Text] [Related]
20. Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation.
Hao B; Gao S; Sang YW; Wang L; Meng XQ; You JY
J Zhejiang Univ Sci B; 2019 Oct.; 20(10):849-860. PubMed ID: 31489804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
